The genomics and transcriptome analyses conducted by A. Hunter Shain et al. showed a sequence of changes occurring in primary melanoma, primarily mutations in the BRAF, RAS, or NF1 genes upstream of the mitogen-activated protein kinases (MAPK) pathway. The gene discussed is NF1; the disease is melanoma.